Speaker illustration

Doctor Rene Boudreau

University of Ottawa Heart Institute, Ottawa (Canada)

Comparing clinical outcomes following 1 year of dual antiplatelet therapy in patients risk stratified by the PRECISE-DAPT and DAPT scores

Event: ESC Congress 2020

Topic: Antiplatelet Drugs

Session: Antithrombotic Therapy Update

Thumbnail

Comparing treatment recommendations for the DAPT and PRECISE-DAPT scores after percutaneous coronary intervention

Event: ESC Congress 2019

Topic: Antiplatelet Drugs

Session: Evolving developments in anti-platelet therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb